德镁医药拟登陆联交所主板 专注皮肤健康领域创新

DoNews
24 Apr

4月22日,德镁医药有限公司向香港联交所递交上市申请,计划以介绍方式在主板挂牌,华泰国际担任独家保荐人。同日,其母公司康哲药业(00867)宣布拟分拆德镁医药独立上市,将通过实物分派方式向股东分配所持德镁医药股份。德镁医药是一家专注于皮肤健康的创新型医药企业,覆盖皮肤处方药及护肤品的研发、生产与销售。据灼识咨询数据,其皮肤处方药收入及适应症覆盖数量均居国内同类企业首位。目前,公司拥有多款已上市及在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10